Scaling up feasibility of the production of solid lipid nanoparticles (SLN).
Solid lipid nanoparticles (SLN/Lipopearls) are widely discussed as colloidal drug carrier system. In contrast to polymeric systems, such as polylactic copolyol capsules, these systems show up with a good biocompatibility, if applied parenterally. The solid lipid matrices can be comprised of fats or waxes and allow protection of incorporated active ingredients against chemical and physical degradation. The SLN can either be produced by "hot homogenisation" of melted lipids at elevated temperatures or a "cold homogenization" process. This paper deals with production technologies for SLN formulations, based on non-ethoxylated fat components for topical application and high pressure homogenization (APV Deutschland GmbH, D-Lübeck). Based on the chosen fat components, a novel and easy manufacturing and scaling up method was developed to maintain chemical and physical integrity of encapsulated active and carrier.
Gohla
S H
SH
Department of Pharmaceutics, Biopharmaceutics and Biotechnology, Free University of Berlin, Hamburg, Germany.
Dingler
A
A
D002214:Capsules; D004337:Drug Carriers; D004339:Drug Compounding; D004345:Drug Industry; D008055:Lipids; D008863:Microspheres
D002214:Capsules; D004337:Drug Carriers; D008055:Lipids